Brentuximab Vedotin
Quick Overview
| Attribute | Value |
|---|---|
| Drug Name | Brentuximab Vedotin |
| DrugBank ID | DB08870 |
| KG Predictions | 5 |
| DL Predictions (≥0.7) | 0 |
| Evidence Level | L5 |
| NPRA Status | Approved |
Sample Brand Names in Malaysia
Predicted Indications
This drug has 5 knowledge graph predictions and 0 high-confidence deep learning predictions.
Top KG Predictions
| Indication | Source |
|---|---|
| classic Hodgkin lymphoma, lymphocyte-rich type | KG |
| Hodgkins lymphoma | KG |
| obsolete Hodgkin’s granuloma | KG |
| Hodgkin’s paragranuloma | KG |
| classic Hodgkin lymphoma | KG |
FHIR Resources
Access drug data via FHIR R4 API:
- MedicationKnowledge:
/fhir/MedicationKnowledge/DB08870
Related Resources
| Resource | Link |
|---|---|
| DrugBank | View on DrugBank |
| PubMed | Search PubMed |
| ClinicalTrials.gov | Search Trials |
Disclaimer
Drug repurposing predictions are for research purposes only. These predictions have not been clinically validated and should not be used for medical decisions. Always consult healthcare professionals.
Drug repurposing predictions are for research purposes only. These predictions have not been clinically validated and should not be used for medical decisions. Always consult healthcare professionals.